These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35434235)

  • 1. Early stage ovarian immature teratoma, surveillance or chemotherapy after surgery? A propensity score matched analysis.
    Zhang X; Yang J; Wang J; Zhang Y; Yang J
    Gynecol Oncol Rep; 2022 Apr; 40():100976. PubMed ID: 35434235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic comparison of active surveillance and adjuvant chemotherapy in the treatment of patients with stage â…  ovarian immature teratoma after fertility-sparing surgery].
    Zhang XY; Yang J; Xiang Y; Wu M; Pan LY; Yang JX
    Zhonghua Fu Chan Ke Za Zhi; 2023 Nov; 58(11):838-845. PubMed ID: 37981770
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of staging surgery and adjuvant chemotherapy in adult patients with apparent stage I pure immature ovarian teratoma after fertility-sparing surgery.
    Wang D; Zhu S; Jia C; Cao D; Wu M; Shen K; Yang J; Xiang Y
    Int J Gynecol Cancer; 2020 May; 30(5):664-669. PubMed ID: 32179695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy.
    Marino G; Grassi T; De Ponti E; Negri S; Testa F; Giuliani D; Delle Marchette M; Dell'Oro C; Fumagalli D; Donatiello G; Besana G; Marchetta L; Bonazzi CM; Lissoni AA; Landoni F; Fruscio R
    Front Oncol; 2024; 14():1330481. PubMed ID: 38371620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis.
    Bergamini A; Sarwar N; Ferrandina G; Scarfone G; Short D; Aguiar X; Camnasio C; Kaur B; Savage PM; Cormio G; Lim A; Pignata S; Mangili G; Seckl MJ
    Eur J Cancer; 2020 Sep; 137():136-143. PubMed ID: 32763784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).
    Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; ViganĂ² R; Tateo S; Villa A; Lorusso D
    Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for pure ovarian immature teratoma and the role of adjuvant chemotherapy in stage I diseases.
    Li S; Zhang X; Zhang T; Yin M; Cao D; Xiang Y; Yang J
    Ann Med; 2023; 55(2):2273984. PubMed ID: 37909181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Adjuvant Chemotherapy in Stage I Pure Ovarian Immature Teratoma: A Systematic Review and Meta-Analysis.
    Li S; Wang Y; Zhang X; Zhang T; Yin M; Yang J
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of chemotherapy in patients with stage I mucinous ovarian cancer undergoing fertility-sparing surgery.
    Long X; Li R; Tang Y; Yang L; Zou D
    Front Oncol; 2022; 12():1028842. PubMed ID: 36425559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
    Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
    Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pure pediatric ovarian immature teratomas: The French experience.
    Pavone R; Dijoud F; Galmiche L; Ro V; Hameury F; Sarnacki S; Orbach D; Briandet C; Pasquet M; Bertrand A; Fresneau B; Faure-Conter C
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28186. PubMed ID: 31981415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric ovarian immature teratoma: Histological grading and clinical characteristics.
    Shinkai T; Masumoto K; Chiba F; Shirane K; Tanaka Y; Aiyoshi T; Sasaki T; Ono K; Gotoh C; Urita Y; Takayasu H; Suzuki R; Sakashita S
    J Pediatr Surg; 2020 Apr; 55(4):707-710. PubMed ID: 31130350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.
    Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD
    Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.
    Schilder JM; Thompson AM; DePriest PD; Ueland FR; Cibull ML; Kryscio RJ; Modesitt SC; Lu KH; Geisler JP; Higgins RV; Magtibay PM; Cohn DE; Powell MA; Chu C; Stehman FB; van Nagell J
    Gynecol Oncol; 2002 Oct; 87(1):1-7. PubMed ID: 12468335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma.
    Swift BE; Covens A; Mintsopoulos V; Parra-Herran C; Bernardini MQ; Nofech-Mozes S; Hogen L
    Int J Gynecol Cancer; 2022 Apr; 32(4):525-531. PubMed ID: 34969829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncological and Reproductive Outcomes of Cystectomy Compared with Unilateral Salpingo-Oophorectomy as Fertility-Sparing Surgery in Patients with Apparent Early Stage Pure Immature Ovarian Teratomas.
    Wang D; Zhu S; Jia C; Cao D; Yang J; Xiang Y
    Ann Surg Oncol; 2021 Oct; 28(11):6684-6693. PubMed ID: 33772392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian immature teratoma: treatment and outcome in a single institutional cohort.
    Vicus D; Beiner ME; Clarke B; Klachook S; Le LW; Laframboise S; Mackay H
    Gynecol Oncol; 2011 Oct; 123(1):50-3. PubMed ID: 21764111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study.
    Mangili G; Giorda G; Ferrandina G; Cormio G; Cassani C; Savarese A; Danese S; Carnelli M; Vasta FM; Perrone AM; Scarfone G; Pignata S; Legge F; Raspagliesi F; Taccagni G; Candiani M; Bogani G; Mascilini F; Bergamini A
    Int J Gynecol Cancer; 2021 Sep; 31(9):1242-1247. PubMed ID: 34035080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb KM
    Am J Clin Oncol; 2021 May; 44(5):195-199. PubMed ID: 33710136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2016 Jun; 26(5):859-64. PubMed ID: 27101582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.